These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date and reported results||2011-000480-27||A Randomised Trial Evaluating the Safety and Efficacy of a Single Low Dose of Intracoronary Insulin-like Growth Factor-1 Following Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial ...||2016-12-16||bad-data|
|Ongoing, reported early||2011-003654-40||A Preliminary Study of Intravenous Ketamine in Selective Serotonin Reuptake Inhibitor (SSRI)-Resistant Depression||not-yet-due|
|Reported results||2011-004554-26||Multi-modal effects of Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism; a randomised placebo-controlled Trial (TRUST)||2016-11-18||due-trials|
|Listed as ongoing, but also has a completion date||2012-001102-14||An international, open label, randomised controlled trial comparing rituximab with azathioprine as maintenance therapy in relapsing ANCA-associated vasculitis||2019-11-21||bad-data|
|Reported results Terminated||2013-000357-41||Identification of the Microbiota Dependent Response to Rifaximin in Irritable Bowel Syndrome Patients||2015-03-18||due-trials|
|Completed, but no date, and reported results Terminated||2014-003138-18||STRIDER Ireland: A Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early‐Onset Intrauterine Growth Restriction||bad-data|
|Completed, report not yet due Terminated||2014-004420-22||Enhancing malignant melanoma immunological engagement using sequential therapy with ipilimumab and electrochemotherapy||2020-03-20||not-yet-due|